Lip and oral cavity carcinoma: genes and variants
Explore variant evidence for Lip and oral cavity carcinoma across 4 analyzed proteins (HRAS, ABL1, BRAF, PIK3CA). Linked ClinVar records include 4 pathogenic or likely pathogenic variants, 0 variants of uncertain significance and 0 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-10. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Lip and oral cavity carcinoma
HRAS: GTPase HRas
Its GTP-bound state activates RAF-MEK-ERK and other pathways downstream of growth-factor receptors. Somatic activating variants drive several cancers, while germline activating variants cause Costello syndrome.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in HRAS have source records linked to Lip and oral cavity carcinoma. Association strength is not clinical gene validity.
ABL1: Tyrosine-protein kinase ABL1
It coordinates cytoskeletal remodeling, adhesion, DNA-damage responses, and growth signaling through tightly regulated tyrosine phosphorylation. Fusion with BCR removes normal control and creates the constitutively active kinase that drives chronic myeloid leukemia and subsets of acute lymphoblastic leukemia.
2 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in ABL1 have source records linked to Lip and oral cavity carcinoma. Association strength is not clinical gene validity.
BRAF: Serine/threonine-protein kinase B-raf
It relays activated RAS signals through MEK and ERK to control proliferation, differentiation, and survival. Activating variants, especially V600E, drive melanoma and several other cancers and create sensitivity to pathway-directed therapies.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in BRAF have source records linked to Lip and oral cavity carcinoma. Association strength is not clinical gene validity.
PIK3CA: Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
Its p110-alpha catalytic activity generates PIP3 and activates AKT-dependent growth, survival, and metabolic signaling downstream of many receptors. Activating variants are frequent cancer drivers and, when present mosaically during development, can cause PIK3CA-related overgrowth spectrum.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in PIK3CA have source records linked to Lip and oral cavity carcinoma. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Lip and oral cavity carcinoma
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| ABL1 E255V | 255 | Protein kinase | Pathogenic / likely pathogenic |
| ABL1 H396R | 396 | Protein kinase | Pathogenic / likely pathogenic |
| BRAF R426T | 426 | Pathogenic / likely pathogenic | |
| PIK3CA E542A | 542 | PIK helical | Pathogenic / likely pathogenic |
Same protein, different disease
- Congenital heart defects and skeletal malformations syndrome also has ClinVar records linked to ABL1 variants; they fall mostly in different places as the Lip and oral cavity carcinoma variants (14 pathogenic / likely pathogenic).
- Leukemia, Philadelphia chromosome-positive, resistant to imatinib also has ClinVar records linked to ABL1 variants; they fall partly in the same places as the Lip and oral cavity carcinoma variants (5 pathogenic / likely pathogenic).
- Chronic myeloid leukemia also has ClinVar records linked to ABL1 variants; they fall mostly in different places as the Lip and oral cavity carcinoma variants (3 pathogenic / likely pathogenic).
- RASopathy also has ClinVar records linked to BRAF variants; they fall mostly in different places as the Lip and oral cavity carcinoma variants (36 pathogenic / likely pathogenic).
- Cardio-facio-cutaneous syndrome also has ClinVar records linked to BRAF variants; they fall mostly in different places as the Lip and oral cavity carcinoma variants (26 pathogenic / likely pathogenic).
- Cardiofaciocutaneous syndrome also has ClinVar records linked to BRAF variants; they fall mostly in different places as the Lip and oral cavity carcinoma variants (17 pathogenic / likely pathogenic).
- Noonan syndrome also has ClinVar records linked to BRAF variants; they fall mostly in different places as the Lip and oral cavity carcinoma variants (11 pathogenic / likely pathogenic).
- Noonan syndrome and Noonan-related syndrome also has ClinVar records linked to BRAF variants; they fall mostly in different places as the Lip and oral cavity carcinoma variants (10 pathogenic / likely pathogenic).
- PIK3CA related overgrowth syndrome also has ClinVar records linked to PIK3CA variants; they fall mostly in different places as the Lip and oral cavity carcinoma variants (30 pathogenic / likely pathogenic).
- Cowden syndrome also has ClinVar records linked to PIK3CA variants; they fall mostly in different places as the Lip and oral cavity carcinoma variants (23 pathogenic / likely pathogenic).
- Megalencephaly-capillary malformation-polymicrogyria syndrome also has ClinVar records linked to PIK3CA variants; they fall mostly in different places as the Lip and oral cavity carcinoma variants (22 pathogenic / likely pathogenic).
- Ovarian neoplasm also has ClinVar records linked to PIK3CA variants; they fall partly in the same places as the Lip and oral cavity carcinoma variants (5 pathogenic / likely pathogenic).
- PIK3CA constitutional syndrome also has ClinVar records linked to PIK3CA variants; they fall mostly in different places as the Lip and oral cavity carcinoma variants (4 pathogenic / likely pathogenic).
Diseases related to Lip and oral cavity carcinoma
- Noonan syndrome, also linked to BRAF, HRAS and PIK3CA
- Colorectal cancer, also linked to ABL1, BRAF and PIK3CA
- Hypertrophic cardiomyopathy, also linked to BRAF and HRAS
- RASopathy, also linked to BRAF and HRAS
- Noonan syndrome and Noonan-related syndrome, also linked to BRAF and HRAS
- Urinary bladder cancer, also linked to HRAS and PIK3CA
- Non-small cell lung carcinoma, also linked to BRAF and PIK3CA
- Costello syndrome, also linked to BRAF and HRAS
- Colon carcinoma, also linked to BRAF and PIK3CA
- Lung cancer, also linked to BRAF and PIK3CA
- Hepatocellular carcinoma, also linked to BRAF and PIK3CA
- Epidermal nevus, also linked to HRAS and PIK3CA
Frequently asked questions
Which genes have records linked to Lip and oral cavity carcinoma?
This view contains 4 analyzed proteins: HRAS, ABL1, BRAF, PIK3CA. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 4 pathogenic or likely pathogenic variants, 0 variants of uncertain significance and 0 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 9 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center